Oops, you're using an old version of your browser so some of the features on this page may not be displaying properly.

MINIMAL Requirements: Google Chrome 24+Mozilla Firefox 20+Internet Explorer 11Opera 15–18Apple Safari 7SeaMonkey 2.15-2.23

Jonathan Ledermann


Jonathan Ledermann

UCL Cancer Institute at University College London

United Kingdom

Jonathan Ledermann is a Professor of Medical Oncology and Clinical Director at UCL Cancer Institute, University College London, and a Consultant Medical Oncologist at UCL Hospitals, London, UK where he has worked for more than 30 years, specialising in the treatment of gynaecological cancers. He has led several national and international trials in ovarian cancer, and he was the Director of the Cancer Research UK & UCL Cancer Trials Centre for over two decades.

He is a Fellow of the Academy of Medical Sciences and a Senior Investigator for the National Institute of Health Research (NIHR). He is the subject Editor for ESMO (European Society for Medical Oncology) Gynaecological Cancer Practice Guidelines.

He was previously Vice President of ESGO (European Society of Gynaecological Oncology), chair of the NCRI UK Gynaecological Cancer Trials Group and chair of the Rare Tumour Group of the Gynaecological Cancer Intergroup.

Last update: July 2023

This site uses cookies. Some of these cookies are essential, while others help us improve your experience by providing insights into how the site is being used.

For more detailed information on the cookies we use, please check our Privacy Policy.

Customise settings
  • Necessary cookies enable core functionality. The website cannot function properly without these cookies, and you can only disable them by changing your browser preferences.